Article Text

Download PDFPDF
Proton pump inhibitors and gastric neoplasia

Statistics from


  • Competing interests: None.


  • Competing interests: In the past 5 years, EJK has received research funding from Altana Pharma, AstraZeneca and Janssen Pharmaceutics, and consulting fees from AstraZeneca.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Leading article
    E J Kuipers
  • Digest
    Robin Spiller Alastair Watson